Blood group B glycosphingolipids (B-GSLs) are substrates of the lysosomal alpha-galactosidase A (AGAL). Similar to its major substrate-globotriaosylceramide (Gb3Cer)-B-GSLs are not degraded and accumulate in the cells of patients affected by an inherited defect of AGAL activity (Fabry disease-FD).
Introduction
Fabry disease (FD, OMIM 301,500) is a rare X chromosome-linked disorder (Xq22.1) of glycosphingolipid (GSL) catabolism. FD is caused by deficient activity of the lysosomal enzyme alpha-galactosidase A (AGAL, EC 3.2.1.22) (Desnick et al. 2001 ). This molecular defect leads to abnormal lysosomal accumulation of GSLs with terminal alphagalactosyl moiety. Endothelial cells, perivascular smooth muscle cells, fibroblasts and cardiomyocytes are predominantly affected. This abnormal intracellular storage is progressive and substantially affects cardiac and renal functions in FD patients. Although the pancreas is an organ expected to be functionally and morphologically afflicted in FD, its biochemical and structural pathologies remain understudied.
The main accumulated AGAL substrate in FD is globotriaosylceramide (Gb3Cer), which belongs to the globo-series of glycolipids.
Gb3Cer is predominantly expressed in the kidney, aorta, spleen and liver (Elleder 2010) .
Blood group B glycosphingolipids (B-GSLs) are additional AGAL substrates. B-GSLs are primarily expressed in the membranes of erythrocytes, though they are also present on the surface of other cell types of blood group B individuals. The blood group B determinant is characterized by the trisaccharide structure Galα1→3(Fucα1→2)Gal, which is usually attached to the lacto-and neolacto-series of glycoproteins or glycolipids (Cartron and Rouger 1995) . Importantly, ABH blood group antigens are secreted into various body fluids (e.g., saliva, tears, semen, urine and gastric juice) (Jaff 2010 ). This release is under a genetic control of allelic secretor genes (Se and se) and is independent of the ABO[H] genes (Schenkel-Brunner 1995; Watkins 2001) .
The pancreas consists of two disparate histological and functional compartments. The exocrine part comprises~90% of the entire gland and is composed of secretory cells organized into acini. Apical portions of the acinar cells are filled with secretory (zymogen) granules that contain precursors of the enzymes of the pancreatic juice (Motta et al. 1997) . On the contrary, the endocrine function of the pancreas is carried out by the hormone (e.g., insulin, glucagon, pancreatic polypeptide, somatostatin and ghrelin) producing cells concentrated to the islets of Langerhans (Cao and Wang 2014) .
Contrary to insulin-producing β-cells (Buschard et al. 2005; Boslem et al. 2012; Manukyan et al. 2015) roles of sphingolipids and their signaling intermediates to pathologies of pancreatic acinar cells have not yet been extensively studied. The pancreas is rich in fucosylated glycoconjugates with antigenic functions. Ito (1992) , Ito et al. (1993) and Uchida et al. (1986) reported that ABH antigens are present on the acinar cells, however, the centroacinar cells, cells of the intercalated pancreatic ducts and islets of Langerhans have been shown to lack these antigens.
Information about the roles and contribution of B-GSLs to the pathogenesis and clinical presentation of FD patients with blood group B (FD-B) is scarce. This is due in part to the relatively low frequency of blood group B in the general population. Abnormal storage of B-GSLs was reported in a single FD patient by Wherrett and Hakomori (1973) who showed that the two major glycolipids with hexasaccharide chains (B-6) and sub-terminal α-galactose, referred to as type 1 (lacto-) and type 2 (neolacto-) chains, could be detected in this patient's pancreas but not in other parenchymatous organs. Electron microscopic studies of FD pancreas are also sporadic. Inclusions in the interstitial fibroblasts, blood vessels and autonomic ganglion cells in FD patient (blood group not specified) were reported by Roth and Roth (1978) . Elleder (2010) detected ultrastructural storage in acinar cells of FD patient with blood group B. Last, the analysis of urine sediment of FD patients showed increased excretion of both types of B-6 glycolipid antigens among secretors of blood group B or AB (Ledvinova et al. 1997) .
To expand this limited information, we examined the pancreatic tissue collected at autopsy of two male FD patients who were blood group B secretors. Having this unique opportunity we report the biochemical profiles of the accumulated GSLs and also define the most structurally affected pancreatic compartments in this specific patient group.
Results

Lipid analysis of pancreatic tissue revealed a striking accumulation of variety of B-GSLs
Neutral GSLs and B-GSLs in lipid extracts of the pancreas, lungs and kidneys were analyzed by HPTLC, HPLC-ESI-MS/MS and FIA-ESI MS/MS. Orcinol detection of neutral GSLs from the pancreatic tissue revealed accumulation of Gb3Cer in all three FD patients irrespective of their blood group (Figure 1 ). Remarkable though was the massive deposition of a multitude of various immunopositive B-GSLs in the FD-B1 pancreas in comparison to control blood group B samples (C-B1 and C-B2). The spectrum of the FD-O pancreatic GSLs displayed no distinct bands in the area corresponding to TLC mobility of the blood group lipid antigens (Figure 1 ). Gb3Cer was substantially less accumulated in the lungs and pancreas than in the kidneys (Table II) .
As for B-GSLs, the immunopositive bands were more pronounced in the kidneys compared with the lungs but were much weaker than in the pancreas. Only trace amounts of B-GSLs were detected in lungs of FD-B patients (Supplementary data, Figure S1 ).
HR-MS spectrum (in the m/z range 1425-1850) of the pancreatic B-GSLs is shown in Figure 2 . Interestingly, a broad array of various oligosaccharides and lipid structures of blood GSLs ranging from 5 to 7 carbohydrate units in the oligosaccharide chain were identified in both FD-B patients. Such a B-GSL rich spectrum was not observed in controls as documented in Figure 2 (Control C-B1 sector of the MS spectra vs the Fabry sector FD-B1).
Because of the technical limits of the MS instrumentation to detect ions with higher m/z than 1800 kDa, only two major B-GSLs containing six (B-6) and seven (B-7) sugar residues were semiquantitatively evaluated by HPLC-ESI-MS/MS. Compared with controls, up to a 30-fold increase in the B-6 glycolipid was identified in both FD-B patients (Table I ). This contrasts with~6-fold elevation of Gb3Cer in FD-B pancreatic homogenates (Table II) .
Massive augmentation of B-GSL antigens in both FD-B patients was confirmed by semi-quantitative densitometry after immunodetection of chromatograms (data not shown). The amounts of other neutral GSLs were normal. The only exception was the Gb3Cer and ceramidedihexoside (CDH) fractions. The latter contains Ga2Cer, which is another minor AGAL substrate represented in the kidneys and elevated in FD patients (Table II) .
Interestingly, the massive GSL storage is accompanied by a distinct decrease in the content of sphingomyelin. This phenomenon was pronounced in all three FD patients irrespective of the blood group (Table II) . On the contrary, a substantial storage of Gb3Cer Fig. 1 . HPTLC analysis of neutral GSLs in the pancreas. Tissue extracts corresponding to identical protein amounts were applied as indicated. Orcinol detection (A) of neutral GSLs in FD pancreas showed increased deposition of Gb3Cer (blue dashed line rectangle). However, in the FD-B1 patient, B-GSLs were identified as additional deposited substances with considerable structural diversity in the carbohydrate moiety, as documented by immunodetection (B). Specific immunodetection with blood group B mouse monoclonal antibody revealed B-GSLs with 6, 7 or 9 monosaccharides in the chain located in the lower part of the chromatogram (red full line rectangle in a). S1 -GSL standards; FD-B2 patient not shown. Details of both detection procedures are given in the Methods.
and CDH fractions was detected in the kidneys and reached a 2-3-fold increase in the concentration of total GSLs in this organ (Supplementary data, Figure S2 ).
Accumulation of blood group B glycoconjugates in pancreatic acinar cells is massive
Increased amounts of the lysosomal marker Cathepsin D was found in the entire exocrine pancreas of FD-B patient compared with weaker staining in control ( Figure 3A and B). Signal for Cathepsin D did not correlate with amylase-positive secretory granules. In the exocrine parts of the FD-B pancreas, massive granular autofluorescence of ceroid was detected. Such an extensive presence of this abnormal intracellular pigment is known in a plethora of lysosomal storage diseases and can be used to spatially identify the storage-affected lysosomes ( Figure 3C and D) .
B-antigens (both glycoproteins and glycolipids) were detected in the acini of the exocrine pancreas and in the vascular endothelial cells in both FD-B patients and controls. Ductal epithelium, endocrine pancreas (islets of Langerhans) and vascular smooth muscle cells were negative for B-antigens (Figures 3E, F and 4A-D) both in controls and FD-B patients. In contrast with the mosaic expression pattern seen in the controls, B-antigens were uniformly expressed in acinar epithelial cells of the patients.
Lipid pre-extraction did not substantially reduce the immunostaining of B-antigens in either FD-B patients or controls (Supplementary data, Figure S3 ). This suggests that the positivity of B-antigens largely corresponds to polar nonlipid glycoconjugates with blood group B determinants.
Similar to B-antigens, Gb3Cer was expressed in vascular endothelial cells. Vascular smooth muscle cells were also positive. Importantly, Gb3Cer positivity was more intense in both FD-B patients than in controls ( Figure 5A -D). Lipid pre-extraction interfered with Gb3Cer immunostaining in endothelial cells both in FD-B patients and controls. Smooth muscle cells in the FD-B patients remained, unlike in the controls, partially Gb3Cer positive ( Figure 5C and D insert). Other cell types, including pancreatic acinar cells, were only weakly positive for Gb3Cer ( Figure 5A and B).
When compared with the intracellular accumulation of the autofluorescent ceroid, which is thought to correspond to the lysosomal storage compartment, Gb3Cer and B-antigens positive vascular endothelial cells were devoid of this abnormal pigment (Supplementary data, Figure S4B ). On the contrary, lysosomal storage in vascular smooth muscle cells was characterized by accumulation of both Gb3Cer and ceroid ( Figure 5D and Supplementary data, Fig. S4B ). B-antigen(s) did not contribute to the lysosomal storage in vascular smooth muscle cells in FD-B patients ( Figure 4D ). Pancreatic acinar cells were affected by accumulation of B-GSL (Figures 3F and 4E) and by massive load of autofluorescent ceroid in combination with a minor amount of nondegraded Gb3Cer ( Figure 5E ). In controls, the autofluorescent material was not detected in any of the listed cell types ( Figure 3C and Supplementary data, Figure S4A ). High-resolution mass spectra of blood group B-GSLs in the pancreas. Differences in lipid spectra between FD-B1 (upper part) and C-B1 (lower part) are in regions corresponding to sphingolipids containing complex carbohydrate structures with 5 and more monosaccharides. Molecular species of major elevated B-6, B-7 (and B5) glycolipids are labeled and their ceramide composition is indicated. The structure of the blood group B antigenic determinant comprising three terminal monosaccharides linked to the oligosaccharide chain type 2 (neolacto-series) is marked in red. Although MS cannot distinguish between isobaric compounds (compounds with the same elemental composition), the authenticity of B-positive GSLs is confirmed by TLC immunodetection, where the peaks of B-6 and B-7 molecular species correspond to immuno-specific bands ( Figure 1 and Supplementary data, Figure S1 ). The X in the GSL represents other possible saccharide units in the oligosaccharide structure. The Y indicates the hydrophobic core ceramide structure of glycolipids. 154.7 ± 0.2 137.1 ± 14.6 36.6 ± 1.1 76.4 ± 6.6 C-B1 4.6 ± 0.2 6.8
Data were obtained by HPLC-ESI-MS/MS analysis of lipid extracts of tissues homogenates. B-glycosphingolipids were semi-quantified with C17:0 Gb3Cer internal standard and by application of methods by Cifkova et al. (2012) and Fan et al. (2013) . For details see Methods. AVG ± SD from technical doublets. FD-B1, FD-B2-Fabry patients, blood group B; FD-O-Fabry patient, blood group O; C-B1-control, blood group B and C-O-control, blood group O.
While B-antigens were predominantly expressed in the apical parts of the cytoplasm of acinar cells ( Figure 3F ), the signal did not colocalize with the signal of secretory granules, ( Figure 4F ). Gb3Cer also did not co-localize with the signal of the secretory granules ( Figure 5F ). Lastly, though lysosomal localization of B-antigens was confirmed by the overlap with the LAMP2 signal ( Figure 4E ).
Discussion
The possible contribution of nondegraded B-GSLs to pancreatic pathophysiology of FD has not been systematically explored since 1973 (Wherrett and Hakomori 1973) . Individual reports have suggested that the defect in degradation of AGAL substrates did not influence the disease phenotype in patients with blood group B or AB (Lidove 2002) . However, the number of analyzed FD-B patients has never been extensive, also due to low frequency of blood group B individuals in the general population (Garratty et al. 2004) .
Gastrointestinal symptoms are relatively frequent (33%) and appear early in life of FD patients (Desnick et al. 2001 ). Recent clinical studies have not associated these symptoms with pancreatic disease, however, the blood group status of these patients was not considered (Vujasinovic et al. 2015) .
This stated we aimed to (i) biochemically characterize the pancreatic storage patterns and (ii) specify the cellular pancreatic populations afflicted by an accumulation of Gb3Cer and/or blood group B compounds.
To compare the spectrum of accumulated metabolites in pancreas of FD-B patients to other tissues, we analyzed GSLs in the kidneys and lungs as representatives of secretory and nonsecretory organs, respectively. In contrast to the previous work (Wherrett and Hakomori 1973) and to a lesser extent than in the pancreas, our current report demonstrates increased amounts of B-GSLs also in the kidneys. The smallest, barely detectable amounts of GSLs were present in the lungs of FD-B patients.
Interestingly, Gb3Cer accumulated less in the pancreas and the lungs than in the kidneys where it dominated (together with Ga2Cer containing CDH fraction). This variability likely relates to differences in metabolic turnover of organ-specific cell types as well as subcellular lipid distribution and/or localization. A remarkable biochemical finding was that besides the dominant species with six (B-6) and seven (B-7) sugar residues, the whole series of highly complex B-GSLs accumulated in the FD-B pancreas (Supplementary data, Figure S1 ).
Under normal conditions, ABH active GSLs with shorter carbohydrate chains (5-15 monosaccharide units per molecule) have been reported at~5% of the total number of ABH sites on erythrocyte membranes. Approximately 75% of compounds carrying ABH active determinants are nonlipid compounds such as glycoproteins (Schenkel-Brunner 1995) .
As such, the results of the biochemical assays that were performed in deproteinated tissue homogenates may not necessarily fully correlate with spatial distribution studies in lipid-extracted tissue sections.
This stated, we next aimed to identify the cellular pancreatic populations afflicted by an accumulation of both Gb3Cer and blood group B compounds. We show that pancreatic vascular endothelial, smooth muscle cells and acinar epithelial cells represent the cell types prominently affected by the lysosomal storage. Importantly, the abnormal acinar deposits consisted mainly of B-glycoconjugates (both GSLs and glycoproteins). In contrast to acinar cells, ductal epithelium and cells of the endocrine part of pancreas were free of storage. This is consistent with report by Ravn and Dabelsteen (2000) , who also failed to detect ABH antigens in the ductal system of the normal exocrine pancreas. In the normal tissue, regardless of the blood group, a mosaic pattern of ABH binding sites was clearly visible, suggesting that it is a usual feature of ABH antigen expression (Ito 1992 ). In FD-B patients, however, the expression of all B-antigens in the pancreatic acinar epithelium was uniform and more intense than in controls suggesting a defect in the catabolic pathway of B-glycoconjugates, previously confirmed by metabolic experiments in fibroblast cultures (Asfaw et al. 2002) . Lipid extraction of the tissue sections eliminated B-polyglycosylceramides and partially reduced the intensity of IHC staining in acinar cells. The residual strong IHC positivity of B-antigens suggested substantial presence of B-active nonlipid glycoconjugates in the pancreas. Lantini and Cossu (1997) demonstrated blood group substances both as cell surface-bound antigens and contents of the secretory granules of acinar and interlobular duct cells. These authors presented specific staining of acinar secretory granules for blood group B antigens with intensive secretion into the pancreatic juice together Data were obtained by FIA-ESI-MS/MS analysis of lipid extracts of tissues homogenates. Sphingolipids were quantified using appropriate internal standards and external calibration point method (Kuchar et al. 2009 ). For further details see Methods. The MS/MS does not differentiate between the glucosyl and galactosyl moieties because of the same mass. Therefore, glucosylceramide and galactosylceramide are quantified as monohexosylceramides (CMH), while lactosylceramide and digalactosylceramide as dihexosylceramides (CDH). FD-B1, FD-B2-Fabry patients, blood group B and FD-O-Fabry patient, blood group O.
with digestive enzymes. In our study, however, neither B-antigens nor Gb3Cer co-localized with secretory granule marker.
It has been known that storage-affected lysosomes accumulate considerable amounts of autofluorescent lipofuscin-like lipopigment ceroid (Terman and Brunk 1998; Elleder 2010; Hulkovaand Elleder 2010) . This material has been defined as a that arises from different pathological conditions of organism, including storage disorders, malnutrition, cell stress, etc. (Seehafer and Pearce 2006; Goebel and Muller 2013) . In FD, ceroid is a major secondary storage component. Storage in pancreatic acinar epithelial cells of our FD-B patients was prominent and characterized by massive B-antigens and autofluorescent ceroid deposition in combination with a small amount of nondegraded Gb3Cer. Lysosomal localization of these compounds was confirmed by co-labeling with lysosomal marker LAMP2.
In contrast to other cell types, moderate Gb3Cer deposition observed in endothelial cells of FD pancreas was not associated with accumulation of ceroid in lysosomes. On the other hand, storage in vascular smooth muscle cells that normally accumulate only minor amounts of Gb3Cer was dominated by substantial deposition of both Gb3Cer and ceroid. In these cells, but not in endothelial cells, Gb3Cer was partially resistant to lipid extraction, probably reflecting modifications of the lysosomal system by long-term storage and intensified by extensive stock of ceroid.
Changes in the lysosomal system were previously shown to interfere with therapeutic protocols. In FD, continuous storage in some cells leads to inefficient clearing of accumulated substrates by the enzyme replacement therapy (Keslova-Veselikova et al. 2008 ). As such, long-term accumulation of B-glycoconjugates in FD-B patients may theoretically worsen their lysosomal pathology. To conclude, our work provides novel and detailed biochemical and morphological data on lysosomal storage in the pancreas of FD-B patients. The results clearly show that different, nondegraded, substrates are expressed and stored in lysosomes of distinct pancreatic cellular populations that have different physiological functions. While acinar cells specifically accumulate glycoconjugates of blood group B and only minimally Gb3Cer, the latter AGAL substrate predominates in the blood vessel cells. Importantly, endocrine cells were completely free of storage. Comparisons of findings between blood group B and O FD patients provide an explanation for the milder affliction of the pancreas in contrast to other organs in which the accumulation of Gb3Cer predominates. We believe that our results strongly substantiate the need for more detailed clinical studies focused on pancreatic (dys)function in FD patients with type B blood group.
Materials and methods
Tissue samples (pancreas, kidneys and lungs) were collected at autopsy from two 52-year-old FD male patients-blood group B D93N) ), and from four age-matched control individuals without diagnosis of any lysosomal storage disease. All samples were fixed with 4% paraformaldehyde.
All three FD patients presented with a classical FD phenotype with typical clinical symptoms (detailed information is available on request). Gastrointestinal problems or pancreatic dysfunction were not part of the medical history of any of the tested FD patients.
The study was approved by the Ethics Committee (reference number 53/13 Grant GAUK 1.LFUK) of the General Teaching Hospital and the First Faculty of Medicine, Charles University in Prague and was performed in accordance with the guidelines of Declaration of Helsinki.
Thin layer chromatography and immunostaining
Prior to the analyses, tissue samples (pancreas, kidneys and lungs) were washed overnight in water, weighed and homogenized in water In Fabry disease, Gb3Cer stains with increased intensity the in pancreatic vessel walls. (C) Small vessels display Gb3Cer in the endothelium, however, large vessels were positive also in the smooth muscle cells. Staining of Gb3Cer was negative after pre-extraction step of lipids from the tissue (insert) (D) Gb3Cer accumulation in the endothelial and smooth muscle cells in the FD-B1 pancreatic vessels is massive. Gb3Cer storage in smooth muscle cells persists after lipid extraction (insert, black arrowheads). (E) Co-localization of Gb3Cer (green signal) with LAMP2 (red signal) demonstrates their localization in lysosomes of Fabry pancreas which is accompanied by the massive accumulation of autofluorescent ceroid (yellow arrowheads). The ceroid can be visually distinguished from DAPI stained nuclei (marked by *) by specific fluorescence and morphology (F) Gb3Cer does not correlate with amylase-positive secretory granules but correlates exclusively with autofluorescent ceroid (yellow arrowheads). Scale bars (a-d) = 50 μm and (e, f) = 10 μm.
using an electric homogenizer. Aliquots were collected to measure protein content (Hartree 1972) . Lipid extracts were prepared by repeated extraction of tissue homogenates using mixtures of chloroform:methanol:water (C:M:W) (20:10:1, 10:20:1, 10:10:1, v/v/v) as described previously (Natomi et al. 1988; Kuchar et al. 2012 ). The dry lipid residue was re-dissolved in C:M (2:1, v/v) in a volume corresponding to the particular protein concentration (in μg/μL) in the original tissue homogenates.
GSLs were separated by high-performance thin layer chromatography (HPTLC) on HPTLC-Alufolien Kieselgel 60 (MERCK, Germany) using C:M: W (65:35:8, v/v/v) . Neutral GSLs were detected with orcinol reagent (0.5% in 2 M H 2 SO 4 in ethanol) by moderately spraying and heating at 105°C for 3-5 min.
B-GSLs were visualized by TLC immunostaining. After blocking (1% ovalbumin and 1% polyvinylpyrrolidone in PBS, for 1 h at 37°C) the TLC sheets were incubated overnight at 4°C with the mouse primary monoclonal antibody to blood group B (mAb 99-806-L001, Exbio, Czech Republic). On the next day, the sheets were washed six times with PBS, blocked with 1% bovine serum albumin in PBS for 30 min at 37°C and incubated with the secondary peroxidaseconjugated goat anti-mouse IgM (Pierce, USA) for 60 min at 37°C. After six additional washes with PBS, specific staining was developed with chromogenic substrate 4-chloro-1-naphthol (Sigma, USA).
Tandem mass spectrometry and high-resolution mass spectrometry
Quantitative determination of sphingolipids in the lipid extracts of the pancreas, lungs and kidneys was performed according to previously described protocols (Kuchar et al. 2009; Hulkova et al. 2012) . Aliquots of lipid extracts that corresponded to 18 μg (pancreas), 9 μg (lungs) and 36 μg (kidneys) of protein were mixed with internal standards. An external calibration point method was used for quantification (Kuchar et al. 2009 ). Samples were reconstituted in 1 mL of methanol or 1 mL of methanol with 5 mM NH 4 COOH for analysis of acidic GSLs or neutral GSLs, respectively.
Measurements were performed using flow injection analysis (FIA) on AB/MDS SCIEX API 4000 triple quadrupole tandem mass spectrometer (MS/MS) equipped with electrospray ionization (ESI) working in the positive (for neutral GSLs) and negative (for acidic GSLs) ion mode. Data were acquired using the single reaction monitoring (SRM) mode. Samples (20 μL) were introduced to the flow of pure methanol (50 μL/min) via Agilent 1290 UPLC system with autosampler. HR-MS data were acquired using the 12T SolariX FTICR mass spectrometer (Bruker Daltonics, Billerica, MA) equipped with a Smartbeam-II 1 kHz laser (Nd:YAG, 355 nm). α-Cyano-4-hydroxycinnamic acid (Bruker Daltonics, Germany) was used as MALDI matrix. Twenty laser shots per spectrum were collected in the positive ion mode. The acquired data were processed and visualized by DataAnalysis 4.0 software (Bruker Daltonics, Germany). The mass spectra were searched for known lipids using mMass software and LipidMAPS database (http://www.lipidmaps.org/ and http://www.mmass.org/) (Strohalm et al. 2010) . B-GSLs were separated and quantified using HPLC-ESI-MS/MS on normal-phase column. SRM pairs were selected according to the data from HR-MS. Cogent Silica-C Column 7.5 cm × 2.1 mm, 4 μm (MicroSolv Technology, Eatontown, NJ) was used for lipid separation. Gradient elution was done in a binary system with mobile phase A consisting of n-hexane: 2-propanol:H 2 O:acetic acid (68:30:2:1) and mobile phase B consisting of 2-propanol:H 2 O:acetic acid (85:15:1); both phases contained 4 mM ammonium acetate for ionization of lipids via protonation. The gradient elution program for HPLC separation started at 100% of mobile phase A and followed a steeping curve to 100% of phase B with increasing flow rate from 50 to 200 μL/min for 60 min.
Because an internal B-GSL standard is not commercially available, B-6 GSL was semi-quantified using C17:0 Gb3Cer internal standard and calculated according to Cifkova et al. (2012) . For the same reason, B-7 glycolipid was semi-quantified using peak area ratios as described by others (Fan et al. 2013 ).
Immunohistochemistry and wide-field light microscopy
Formaldehyde-fixed and paraffin-embedded pancreatic tissues from FD-B patient were used for IHC detection of blood group B antigens. The tissue was cut into 4 μm thick sections and deparaffinized with three xylene washes (5 min each), one acetone wash (2 min), two ethanol washes (2 min each) and two washes in distilled water (2 min each), all at room temperature. Endogenous peroxidase in the tissue sections was blocked with 1% sodium azide and 0.3% H 2 O 2 for 30 min and sections were further blocked with 5% fetal bovine serum in PBS. Then the sections were incubated with mouse IgM monoclonal antibodies against blood group B trisaccharide antigenic determinant (mAb 99-806-L001, Exbio, Czech Republic) diluted 1:25 at 4°C overnight. After four PBS washes, anti-mouse EnVision+ System-HRP and diaminobenzidine (DAB)+ Substrate Chromogen system (both DakoCytomation, Glostrup, Denmark) were used for detection of the primary antibodies. Last, the sections were counterstained with Harris hematoxylin, dehydrated and mounted in Solacryl BMX (Penta, Czech Republic).
Cryostat sections prepared from the fixed pancreas were used for lipid immunohistochemistry (IHC). Formaldehyde-fixed tissue blocks were frozen in liquid nitrogen and 5 μm thick sections were cut with cryostat microtome (Leica Biosystems, Nussloch GmbH). Sections were air dried, blocked as described above and incubated with primary mAb overnight at 4°C. Mouse IgG2b anti-Gb3Cer antibody (370,680, Seikagaku, Japan) and mouse IgM antibody against blood group B were diluted 1:50 and 1:20, respectively. Parallel sections were stained before and after the total extraction of lipids with the following procedure: 50% ethanol (10 min), mixture consisting of C:M:W(4:8:3, v/v/v, 6 h), mixture consisting of C:M (2:1, v/v, overnight), and final washing in 50% ethanol (5 min) and in distilled water (5 min), all at room temperature. Primary antibodies were detected with anti-mouse EnVision+ System-HRP with DAB as a chromogen, the sections were counterstained with Harris hematoxylin and mounted in Immu-Mount medium (Shandon, Pittsburgh, PA).
Confocal microscopy-co-localization studies of blood group B antigens in the pancreas
The co-localization studies of blood group B antigens with other markers (see below) were performed in paraffin-embedded tissue sections of the FD-B1 pancreas. Sections were washed with a series of solvents and distilled water as described above. The primary antibodies against α-Amylase (rabbit, A8273, Sigma, USA), Cathepsin D (rabbit, ab75852, Abcam, UK) and lysosomal-associated membrane protein type 2 (LAMP2, rabbit, NBP1-02965, Novus Biologicas, Littleton, CO) were chosen to specifically detect secretory granules (anti-amylase) and lysosomes (anti-cathepsin D and anti-LAMP2). Secondary detection of the primary antibodies used Alexa Fluor 488-conjugated goat anti-rabbit IgG and Alexa Fluor 568-conjugated goat anti-mouse IgG (Molecular Probes, Invitrogen/ThermoScientific, Carlsbad, CA). Primary antibodies were incubated for 1 h at 37°C. Secondary antibodies were incubated for 1 h at 37°C. Nuclei were visualized using DAPI (4′, 6-diamidino-2-phenylindole, dihydrochloride, Invitrogen/ThermoScientific, Carlsbad, CA) for 15 min at 37°C.
The sections were scanned with Laser Scanning Confocal Microscope Leica SP8X (Leica Microsystems GmbH, Wetzlar, Germany). All confocal images were acquired with HC PL APO 63x/1.40 OIL CS2 objective. DAPI, Alexa Fluor 488 and Alexa Fluor 568 were excited with 405 nm, 499 nm and 577 nm, respectively. The detector emission wavelengths were set to 410-489 nm, 505-582 nm and 589-726 nm, respectively. Alexa Fluor dyes were detected with HybridDetectors using counting mode in 12 bits per channel and gated detection (0.3-12 ns). The Nyquist resolution used for image acquisitions was 41 nm/px. The individual channels were deconvolved by Maximum likelihood estimation algorithm using HuygensPro software (Scientific Volume Imaging b.v., Hilversum, the Netherlands). Cropping, final resolution adjustments and conversion to 8 bits per channel was done in LAS X (Leica Microsystems) and Adobe Photoshop CS6 (Adobe Systems, Inc., San Jose, CA).
Detection of the autofluorescent ceroid
Ceroid was detected by its autofluorescence in both paraffin and cryostat sections. For wide-field epi-fluoresce, Nikon E800 Microscope (Nikon Instruments, Inc., Melville, NY) equipped with the UV-2A filter cube (Ex355/50DM400Em420LP) and Olympus DP70 Digital Camera (Olympus Corporation, Shinjuku, Tokyo, Japan) were used. The resultant images ( Figure 3C and D, and Supplementary data, Figure S4A and S4B) contain the autofluorescent signal coded in yellow-green.
In the confocal setup, autofluorescence of ceroid can be detected in all three channels with the maximum being in the 410-489 nm channel. As a result, ceroid autofluorescence is coded in blue in Figures 4E, F and 5E, F. DAPI labeled nuclei were discriminated from the autofluorescent signal of ceroid by their specific morphology.
Supplementary data
Supplementary data is available at GLYCOBIOLOGY online.
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